Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Accounts Payables (2022 - 2025)

Envoy Medical's Accounts Payables history spans 4 years, with the latest figure at $2.7 million for Q3 2025.

  • For Q3 2025, Accounts Payables rose 52.59% year-over-year to $2.7 million; the TTM value through Sep 2025 reached $2.7 million, up 52.59%, while the annual FY2024 figure was $1.7 million, 6.31% up from the prior year.
  • Accounts Payables for Q3 2025 was $2.7 million at Envoy Medical, up from $1.6 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $3.4 million in Q3 2023 and bottomed at $658899.0 in Q1 2022.
  • The 4-year median for Accounts Payables is $1.6 million (2023), against an average of $1.6 million.
  • The largest annual shift saw Accounts Payables surged 215.59% in 2023 before it crashed 48.03% in 2024.
  • A 4-year view of Accounts Payables shows it stood at $1.0 million in 2022, then surged by 54.94% to $1.6 million in 2023, then rose by 6.31% to $1.7 million in 2024, then soared by 62.29% to $2.7 million in 2025.
  • Per Business Quant, the three most recent readings for COCH's Accounts Payables are $2.7 million (Q3 2025), $1.6 million (Q2 2025), and $1.7 million (Q1 2025).